A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care
Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, Abangma G, Dakin H, Little P
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, Abangma G, Dakin H, Little P. A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care. Health Technology Assessment 2009; 13(37): 1-140
Authors' objectives
To determine the clinical effectiveness and cost-effectiveness of topical mometasone in children with bilateral otitis media with effusion (OME).
Authors' conclusions
Study found that the use of topical intranasal corticosteroids is very unlikely to be a clinically effective treatment for otitis media with effusion in children in the primary care setting
Administration, Intranasal; Adrenal Cortex Hormones /administration & Child; Child, Preschool; Female; Great Britains; Male; Otitis Media with Effusion /drug therapy /physiopathology; Primary Health Care; State Medicine; Treatment Outcome; dosage /pharmacology /therapeutic use
Language Published
English
Country of organisation
England
Address for correspondence
NETSCC, Health Technology Assessment, Alpha House, University of Southampton Science Park, Southampton, SO16 7NS UK Tel: +44 23 8059 5586 Email: hta@hta.ac.uk